The main indication for PPI are gastric and duaodenal ulcers, reflux disease, eradication of HP, prevention of ulceration caused by NSAID in high-risk patients. Consumption analysis showed that proper PPI prescribing accounts for 25-39 prescriptions and 53-69% of PPI prescriptions are off-label. The aim of the study is to analyze the patterns of use of PPI drugs and development based on it algorithms of conduct when dispensing drugs from the PPI or AH2 group at a pharmacy. The study includes an analysis of data related to the sale of PPI and AH2 drugs and surveys among patients in community pharmacy. In the survey analysis the reasons and indication for PPI usage, the dosing and duration of therapy were assessed. The analysis of pharmacy transactions were used to assess the combination therapy of PPI and other medications. The results of analysis showed that patient prolonged the duration of PPI therapy, >90% of patients declared the use of PPI for more than 6 months. More than 20% were unable to determine whether they have improved thanks to PPI, and more than 1/3 declared that the medication was previously prescribed by the physician. Pharmacy transaction analysis were based on more than 200 thousand records. The most often, PPI were sold together with cardiovascular medication, in 15% they were used together with anti-inflammatory and anti-rheumatic med ; ications. Over 43% of sales were made to patients over 60 years of age. Based on the analysis we create the algorithms for pharmacists counselling patient, who want to buy PPI and dispensing PPI on prescription. These algorithms indicate the correct way to verify the indications for the use.
Rada Dyscypliny Nauki farmaceutyczne
May 23, 2024
May 23, 2024
4
0
http://dl.cm-uj.krakow.pl:8080/publication/5115
Edition name | Date |
---|---|
ZB-140037 | May 23, 2024 |
Jaworska, Elżbieta
Pelka, Patrycja
Krakowska-Stasiak, Małgorzata